FB

Friedman BioVentures

North America, California, United States, San Diego

Description

Friedman BioVentures is a firm that invests in early-stage companies with promising technologies.

Investor Profile

Friedman BioVentures has made 9 investments, with 1 in the past 12 months and 44% as lead.

Stage Focus

  • Seed (44%)
  • Series A (33%)
  • Series B (22%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Life Science
  • Health Care
  • Health Diagnostics
  • Pet
  • Veterinary
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Friedman BioVentures frequently co-invest with?

Access Biotechnology
North America, New York, United States, New York
Co-Investments: 1
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Tachyon Ventures
North America, California, United States, Los Angeles
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 2
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 4
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2

Which angels does Friedman BioVentures often collaborate with?

CC
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Friedman BioVentures?

Trio Pharmaceuticals

San Diego, California, United States

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

BiotechnologyHealth CareMedicalTherapeutics
SeedDec 3, 2024
Amount Raised: $3,100,000
Hillhurst Biopharmaceuticals

San Diego, California, United States

Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.

Advanced MaterialsAlternative MedicineBiotechnologyLife SciencePharmaceuticalTherapeutics
SeedDec 20, 2023
Trio Pharmaceuticals

San Diego, California, United States

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

BiotechnologyHealth CareMedicalTherapeutics
SeedMar 28, 2023
Amount Raised: $2,200,000
PetDx

La Jolla, California, United States

PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.

BiotechnologyHealth DiagnosticsLife SciencePetVeterinary
Series BDec 9, 2021
Amount Raised: $62,000,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series BMar 1, 2021
Amount Raised: $100,000,000
Model Medicines

La Jolla, California, United States

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.

Artificial Intelligence (AI)BiotechnologyMachine LearningMedicalPharmaceutical
SeedFeb 1, 2021
Amount Raised: $4,100,000
PetDx

La Jolla, California, United States

PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.

BiotechnologyHealth DiagnosticsLife SciencePetVeterinary
Series AJun 1, 2020
Amount Raised: $10,000,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series AJan 6, 2020
Amount Raised: $10,600,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series AMay 14, 2019
Amount Raised: $3,000,000